All statements regarding the Company's expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations or listing on an exchange including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond the Company's control and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements
Biochim Biophys Acta Mol Cell Biol Lipids 1868(4):159287 Zhong D et al (2023) Targeting mPGES-2 to protect against acute kidney injury via inhibition of ferroptosis dependent on p53
Other drugs include: Sulfonamides: cotrimoxazole Beta-lactam: penicillins, cephalosporins Anti-convulsants: lamotrigine, carbamazepine, phenytoin, phenobarbitone Allopurinol Paracetamol/acetaminophen Nevirapine (non-nucleoside reverse transcriptase inhibitor) Nonsteroidal anti-inflammatory drugs (NSAIDs) (oxicam type mainly) The anticancer drugs, PD-1 inhibitors
R750 PRP vampire facial-delivers PRP to dermal layer of the skin to promote rejuvenation and improve signs of ageing